Company Filing History:
Years Active: 2015-2019
Title: The Innovative Contributions of Adrian Recinos
Introduction
Adrian Recinos is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of dengue hemorrhagic fever. With a total of 2 patents, his work has the potential to improve patient outcomes in tropical medicine.
Latest Patents
Recinos' latest patents focus on methods and biomarkers for the detection of dengue hemorrhagic fever. The first patent provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patients at risk of developing dengue hemorrhagic fever (DHF). This invention highlights the importance of plasma biomarkers, including the complement factor D to complement factor H (FactorD/FactorH) ratio, as well as levels of IL2, desmoplakin, and high molecular weight albumin. These biomarkers are crucial for assessing the risk of DHF in patients.
The second patent also addresses the detection of dengue hemorrhagic fever. It outlines methods for identifying patients with dengue-like symptoms who are at risk of DHF. This inventive method involves detecting specific biomarkers in samples from dengue-infected patients, including IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin. These biomarkers are utilized in a predictive MARS model to effectively identify patients at risk of developing DHF.
Career Highlights
Adrian Recinos is affiliated with the University of Texas System, where he continues to advance his research and innovation in medical diagnostics. His work is characterized by a commitment to improving healthcare through scientific discovery and technological advancement.
Collaborations
Recinos collaborates with esteemed colleagues, including Allan R Brasier, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the medical field.
Conclusion
Adrian Recinos exemplifies the spirit of innovation in the medical diagnostics arena. His patents and ongoing research efforts are paving the way for improved detection methods for dengue hemorrhagic fever, ultimately benefiting patient care and health outcomes.